Literature DB >> 18603412

Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus.

Mohamad A Mikati1, Michele Zeinieh, Ralph Abi Habib, Jimmy El Hokayem, Amal Rahmeh, Marwan El Sabban, Julnar Usta, Ghassan Dbaibo.   

Abstract

Status epilepticus (SE) induces a number of events leading to programmed cell death (PCD). The aim of our work is to study the time sequence of activation of different factors in experimental SE (intraperitoneal kainic acid (KA) model). We studied ceramide, a known mediator of apoptosis in multiple models, sphingomyelinases (SMases), enzymes that break down sphingomyelin and increase ceramide thus leading to apoptosis in many models, Bcl(2), Bax, and caspase-3. SE induced a sustained ceramide increase starting 2h after kainic acid injection followed by an increase in Bax protein at 6 and 12h, and the appearance of caspase-3-activated fragment (caspase-3a) immunostaining and TUNEL positivity at 12h. Status epilepticus also induced an increase in acidic and neutral sphingomyelinases that preceded (acidic sphingomyelinase) and parallelled (acidic and neutral sphingomyelinase) the increases in ceramide. These data suggest that, in this model, Bax is activated early in the process and that its increase is sustained till 12h after kainic acid injection which is the time of first appearance of caspase-3 activation and TUNEL positivity, and that SMases contribute to increases in ceramide levels during and after status epilepticus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603412     DOI: 10.1016/j.eplepsyres.2008.05.009

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  8 in total

1.  Deletion of Puma protects hippocampal neurons in a model of severe status epilepticus.

Authors:  T Engel; S Hatazaki; K Tanaka; J H M Prehn; D C Henshall
Journal:  Neuroscience       Date:  2010-04-01       Impact factor: 3.590

2.  MiR-181b inhibits P38/JNK signaling pathway to attenuate autophagy and apoptosis in juvenile rats with kainic acid-induced epilepsy via targeting TLR4.

Authors:  Li Wang; Li-Fang Song; Xiao-Yi Chen; Yan-Li Ma; Jun-Fang Suo; Jing-He Shi; Guo-Hong Chen
Journal:  CNS Neurosci Ther       Date:  2018-05-28       Impact factor: 5.243

Review 3.  Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.

Authors:  Achraf A Shamseddine; Michael V Airola; Yusuf A Hannun
Journal:  Adv Biol Regul       Date:  2014-10-27

4.  Transient protective effect of B-vitamins in experimental epilepsy in the mouse brain.

Authors:  Tamer Rabie; Wolfgang Mühlhofer; Thomas Bruckner; Anna Schwab; Alexander T Bauer; Manfred Zimmermann; Dieter Bonke; Hugo H Marti; Johannes Schenkel
Journal:  J Mol Neurosci       Date:  2009-09-24       Impact factor: 3.444

5.  Characterization of acid sphingomyelinase activity in human cerebrospinal fluid.

Authors:  Christiane Mühle; Hagen B Huttner; Silke Walter; Martin Reichel; Fabio Canneva; Piotr Lewczuk; Erich Gulbins; Johannes Kornhuber
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

6.  Functional implications of novel human acid sphingomyelinase splice variants.

Authors:  Cosima Rhein; Philipp Tripal; Angela Seebahn; Alice Konrad; Marcel Kramer; Christine Nagel; Jonas Kemper; Jens Bode; Christiane Mühle; Erich Gulbins; Martin Reichel; Cord-Michael Becker; Johannes Kornhuber
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

7.  Identification of novel functional inhibitors of acid sphingomyelinase.

Authors:  Johannes Kornhuber; Markus Muehlbacher; Stefan Trapp; Stefanie Pechmann; Astrid Friedl; Martin Reichel; Christiane Mühle; Lothar Terfloth; Teja W Groemer; Gudrun M Spitzer; Klaus R Liedl; Erich Gulbins; Philipp Tripal
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

8.  Exploratory Metabolomics Profiling in the Kainic Acid Rat Model Reveals Depletion of 25-Hydroxyvitamin D3 during Epileptogenesis.

Authors:  Svenja Heischmann; Kevin Quinn; Charmion Cruickshank-Quinn; Li-Ping Liang; Rick Reisdorph; Nichole Reisdorph; Manisha Patel
Journal:  Sci Rep       Date:  2016-08-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.